A Tailored, Web-Based Self-Management Program to Treat Pain in Chronic Pancreatitis

Not Applicable

Not yet recruiting

• Conditions: Chronic Pancreatitis

• Registration Number: NCT07223554
• Lead Sponsor: University of Michigan

Brief Summary

This research study aims to evaluate the feasibility and acceptability of a web-based, self-guided, disease-specific self-management program tailored to individual health status profiles for patients with painful chronic pancreatitis.

Detailed Description

This is a single center, prospective, open-label, pilot trial of 30 patients with painful chronic pancreatitis (CP). Participants will be assigned to a 12-week web-based, self-management program known as PainGuide that has been adapted to CP. Participants will receive specific instruction to complete one module a week over the first 4 weeks. Next, participants will receive weekly tailored messaging for the last 8 weeks using symptom scores from baseline assessments and will be asked to complete modules that best address participants symptoms. Participants will complete online surveys at baseline, 4 weeks, 8 weeks, and 12 weeks, and will be interviewed at the end of program to understand participants perceptions on the intervention.

Study Timeline

• Status Verified: 2025-10
• Study First Submitted: 2025-10-29
• Study First Submitted QC: 2025-10-29
• Last Update Submitted: 2025-10-29
• Study First Posted: 2025-11-03
• Last Update Posted: 2025-11-03
• Study Start: 2025-12-01
• Primary Completion: 2027-03
• Study Completion: 2027-03-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Physician diagnosis of chronic pancreatitis.
• Abdominal pain for ≥ 3 months and of intensity rated at least 4 or higher on a 0-10 Numeric Rating Scale at least once in the last month.
• Access to an Internet-connected device (e.g. computer or phone).

Exclusion Criteria

• Unable to speak or read English as the web-based program is currently in English language only.
• Incarcerated individuals.
• Currently receiving chemotherapy.
• Suspected or diagnosed pancreatic cancer.
• Currently receiving psychotherapy or cognitive behavioral therapy.
• Serious visual difficulties that would limit completing the web-based program.
• Substantial cognitive impairment or mental illness that would prevent providing informed consent and completion of questionnaires.
• Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study.
• Actively enrolled in another clinical trial for chronic pancreatitis.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Proportion of enrolled participants that log in at least once during weeks 1-4 and at least once to the recommended modules during weeks 5-12.	12 weeks	This number is used to determine adherence to the intervention.
Proportion of participants with an average item score of ≥4 out of 5 on the Acceptability of Healthcare Interventions Questionnaire	12 weeks	This is a validated 8-item questionnaire that assesses acceptability using a 5-point Likert scale rated 1-5.

Secondary Outcome Measures

Name	Time	Method
Proportion of participants approached that enroll in the study.	Approximately 1 year (during recruitment period)	This number is used to determine enrollment feasibility to the web-based program in patients with painful CP.
Proportion of enrolled participants that log in at least once during the 12-week program	12 weeks	This number is used to determine minimal adherence to the web-based program in patients with painful CP.
Proportion of enrolled participants that log in at least once a week during weeks 1-4 and at least once a week to the recommended modules during weeks 5-12.	12 weeks	This number is used to determine maximal adherence to the web-based program in patients with painful CP.
Number of logins per participant during the 12-week intervention	12 weeks	This number is used to determine engagement with the web-based program in patients with painful CP.
Proportion of fully completed questionnaires by the total number given to participants	12 weeks	This number is used to assess the feasibility of data collection procedures.
Proportion of participants who scores the general acceptability item on the acceptability scale ≥4 out of 5	12 weeks	This is a validated 8-item questionnaire that assesses acceptability using a 5-point Likert scale rated 1-5.
Proportion of participants that feel the web-based program is easy and intuitive to use based on a usability score > 68 on the System Usability Scale (SUS)	12 weeks	This is a validated 10-item questionnaire that measures the perceived usability of a system focusing on ease of use, efficiency, and overall satisfaction. Participants score from 1 (strongly disagree) to 5 (strongly agree). To calculate the SUS score, respondents' ratings are adjusted: subtract 1 from the score for odd-numbered items and subtract each score from 5 for even-numbered items. The adjusted scores are then summed and multiplied by 2.5, yielding a total score ranging from 0 to 100. Generally, a SUS score above 68 indicates above-average usability, though this benchmark can vary with different systems.

Trial Locations

Locations (1)

University of Michigan; 🇺🇸 Ann Arbor, Michigan, United States